We just received data on a new analyst forecast for $ARDX. Laura Chico from Wedbush set a price target of 19.0 for ARDX.
To track analyst ratings and price targets for $ARDX, check out Quiver Quantitative's $ARDX forecast page.
Should you buy $ARDX?
Some analysts are better than others. To view the past performance of Wedbush, check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$ARDX Price Targets
Multiple analysts have issued price targets for $ARDX recently. We have seen 6 analysts offer price targets for $ARDX in the last 6 months, with a median target of $15.0.
Here are some recent targets:
- Laura Chico from Wedbush set a target price of $19.0 on 01/21/2026
- Julian Harrison from BTIG set a target price of $17.0 on 01/09/2026
- Yigal Nochomovitz from Citigroup set a target price of $14.0 on 01/09/2026
- Christopher Raymond from Piper Sandler set a target price of $16.0 on 01/09/2026
- Joseph Thome from TD Cowen set a target price of $10.0 on 10/31/2025
- Ryan Deschner from Raymond James set a target price of $12.0 on 08/05/2025
$ARDX Insider Trading Activity
$ARDX insiders have traded $ARDX stock on the open market 15 times in the past 6 months. Of those trades, 0 have been purchases and 15 have been sales.
Here’s a breakdown of recent trading of $ARDX stock by insiders over the last 6 months:
- LAURA A WILLIAMS (Chief Patient Officer) has made 0 purchases and 5 sales selling 142,687 shares for an estimated $911,298.
- MICHAEL RAAB (President & CEO) has made 0 purchases and 2 sales selling 92,574 shares for an estimated $530,610.
- ERIC DUANE FOSTER (Chief Commercial Officer) has made 0 purchases and 2 sales selling 21,122 shares for an estimated $122,994.
- ELIZABETH A GRAMMER (See Remarks) has made 0 purchases and 2 sales selling 11,836 shares for an estimated $67,840.
- MIKE KELLIHER (See Remarks) has made 0 purchases and 2 sales selling 10,977 shares for an estimated $62,917.
- JOSEPH JAMES REILLY (See Remarks) sold 11,086 shares for an estimated $61,382
- JUSTIN A RENZ (Chief Financial Officer) sold 7,037 shares for an estimated $41,741
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ARDX Hedge Fund Activity
We have seen 115 institutional investors add shares of $ARDX stock to their portfolio, and 92 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MILLENNIUM MANAGEMENT LLC removed 4,021,242 shares (-34.5%) from their portfolio in Q3 2025, for an estimated $22,157,043
- BANK OF AMERICA CORP /DE/ removed 2,873,791 shares (-52.0%) from their portfolio in Q3 2025, for an estimated $15,834,588
- VANGUARD GROUP INC added 2,337,672 shares (+14.6%) to their portfolio in Q3 2025, for an estimated $12,880,572
- MARSHALL WACE, LLP removed 2,307,610 shares (-20.5%) from their portfolio in Q3 2025, for an estimated $12,714,931
- NUVEEN, LLC added 1,685,009 shares (+48.3%) to their portfolio in Q3 2025, for an estimated $9,284,399
- TWO SEAS CAPITAL LP removed 1,539,416 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $8,482,182
- EVERSEPT PARTNERS, LP added 1,429,377 shares (+inf%) to their portfolio in Q3 2025, for an estimated $7,875,867
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
